{
    "clinical_study": {
        "@rank": "131095", 
        "acronym": "ReMePARK", 
        "arm_group": {
            "arm_group_label": "PD Cohort", 
            "description": "Subjects diagnosed with Parkinson's disease"
        }, 
        "biospec_descr": {
            "textblock": "Serum and/or saliva"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "The objective of the study is to assess the effect of motor, non-motor and genetic factors\n      on the progression of Parkinson's disease as well as its impact on complications rates.\n\n      A large sample of Mexican subjects with Parkinson's disease attending several referral\n      centers will be included.\n\n      Data collected will include disease severity and motor scales, non-motor scales as well as\n      genotyping for monogenic forms of the disease.\n\n      Assessments will be performed every 6 months for two years."
        }, 
        "brief_title": "Motor, Non-motor and Genetic Determinants of Progression in Parkinson's Disease: A Mexican Multicenter Cohort Study", 
        "completion_date": {
            "#text": "August 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Parkinson's Disease", 
        "condition_browse": {
            "mesh_term": "Parkinson Disease"
        }, 
        "detailed_description": {
            "textblock": "Demographic and clinical data will be collected after obtaining a signed informed consent.\n\n      Recruitment will be competitive. Data collected includes age, gender, motor phenotype, age\n      at onset, age at diagnosis, smoking history, family history, antiparkinsonic treatment,\n      other treatments and a complete neurological evaluation."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Diagnosis of Parkinson's disease by the United Kingdom Parkinson's disease Society\n             Brain Bank Criteria\n\n          -  Any gender\n\n          -  Any Hoehn and Yahr stage\n\n          -  Written informed consent\n\n        Exclusion Criteria:\n\n          -  Severe comorbidity that may limit proper neurological evaluation as judged by the\n             investigator\n\n          -  Subjects with atypical or secondary parkinsonism"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "95 Years", 
            "minimum_age": "20 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Subjects diagnosed with idiopathic or genetic Parkinson's disease attending any of the\n        participant sites in Mexico."
            }
        }, 
        "enrollment": {
            "#text": "440", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 28, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01865877", 
            "org_study_id": "INNN 35/12", 
            "secondary_id": "182133"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Parkinson's disease", 
            "Motor", 
            "Non-motor", 
            "Progression", 
            "Complications"
        ], 
        "lastchanged_date": "May 28, 2013", 
        "link": {
            "description": "Instituto Nacional de Neurolog\u00eda y Neurocirug\u00eda", 
            "url": "http://www.innn.salud.gob.mx"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Guadalajara", 
                        "country": "Mexico", 
                        "state": "Jalisco", 
                        "zip": "44280"
                    }, 
                    "name": "Hospital Civil de Guadalajara"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Monterrey", 
                        "country": "Mexico", 
                        "state": "Nuevo Le\u00f3n", 
                        "zip": "64460"
                    }, 
                    "name": "Hospital Universitario"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "contact": {
                    "email": "acervantes@innn.edu.mx", 
                    "last_name": "Amin Cervantes-Arriaga, MD,MSc", 
                    "phone": "+5256063822", 
                    "phone_ext": "5018"
                }, 
                "facility": {
                    "address": {
                        "city": "Mexico City", 
                        "country": "Mexico", 
                        "zip": "14269"
                    }, 
                    "name": "Instituto Nacional de Neurolog\u00eda y Neurocirug\u00eda"
                }, 
                "investigator": {
                    "last_name": "Mayela Rodr\u00edguez-Violante, MD,MSc", 
                    "role": "Sub-Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mexico City", 
                        "country": "Mexico", 
                        "zip": "06726"
                    }, 
                    "name": "Hospital General de M\u00e9xico"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mexico City", 
                        "country": "Mexico", 
                        "zip": "11520"
                    }, 
                    "name": "Hospital Espa\u00f1ol"
                }, 
                "status": "Active, not recruiting"
            }
        ], 
        "location_countries": {
            "country": "Mexico"
        }, 
        "number_of_groups": "1", 
        "official_title": "Motor, Non-motor and Genetic Determinants of Progression and Complications in Parkinson's Disease: A Multicenter Cohort Study in Mexican Population (ReMePArk)", 
        "other_outcome": {
            "description": "Prevalence and incidence of depression, apathy, cognitive decline, psychosis and impulse control disorder will be determined.", 
            "measure": "To assess the change in prevalence of neuropsychiatric symptoms over time", 
            "safety_issue": "No", 
            "time_frame": "Every 12 months for 2 years"
        }, 
        "overall_contact": {
            "email": "acervantes@innn.edu.mx", 
            "last_name": "Amin Cervantes-Arriaga, MD,MSc", 
            "phone": "+525556063822", 
            "phone_ext": "5018"
        }, 
        "overall_contact_backup": {
            "email": "mrodriguez@innn.edu.mx", 
            "last_name": "Mayela Rodr\u00edguez-Violante, MD,MSc", 
            "phone": "+525556063822", 
            "phone_ext": "5018"
        }, 
        "overall_official": {
            "affiliation": "Instituto Nacional de Neurolog\u00eda y Neurocirug\u00eda", 
            "last_name": "Amin Cervantes-Arriaga, MD,MSc", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Mexico: National Council of Science and Technology", 
                "Mexico: Ethics Committee", 
                "Mexico: Federal Commission for Sanitary Risks Protection"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Motor symptoms will be assessed by proper and validated motor scales; also minimal clinically important change will be determined.", 
            "measure": "To assess motor scale change over time", 
            "safety_issue": "No", 
            "time_frame": "Every 6 months for 2 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01865877"
        }, 
        "responsible_party": {
            "investigator_affiliation": "El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez", 
            "investigator_full_name": "Amin Cervantes-Arriaga", 
            "investigator_title": "MD, MSc", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Non-motor symptoms will be assessed using proper validated scales. Frequency and severity will be recorded.", 
                "measure": "To assess non-motor symptoms over time", 
                "safety_issue": "No", 
                "time_frame": "Every 6 months for 2 years"
            }, 
            {
                "description": "Health-related quality of life will be assessed with proper validated clinimetric instruments.", 
                "measure": "To assess quality of life change over time.", 
                "safety_issue": "No", 
                "time_frame": "Every 6 months for 2 years"
            }, 
            {
                "description": "Caregiver burden will be assessed by proper validated scales.", 
                "measure": "To assess caregiver burden as disease progresses", 
                "safety_issue": "No", 
                "time_frame": "Every 12 months for 2 years"
            }
        ], 
        "source": "El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez", 
        "sponsors": {
            "collaborator": {
                "agency": "National Council of Science and Technology, Mexico", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "2 Years", 
        "verification_date": "May 2013"
    }
}